Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report)’s stock price rose 0.9% during mid-day trading on Tuesday. The company traded as high as $39.2550 and last traded at $39.1440. 155 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 3,047 shares. The stock had previously closed at $38.81.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on CZMWY. Morgan Stanley started coverage on Carl Zeiss Meditec in a report on Wednesday, September 2nd. They issued an “underweight” rating for the company. Zacks Research upgraded Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 6th. The Goldman Sachs Group cut Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a report on Monday, October 5th. Finally, UBS Group lowered Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday, August 11th. Two research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Strong Sell”.
View Our Latest Analysis on CZMWY
Carl Zeiss Meditec Trading Up 0.0%
The company’s 50-day moving average price is $36.61 and its 200-day moving average price is $32.89.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG is a medical technology company headquartered in Jena, Germany, and part of the ZEISS Group. The company develops, manufactures and distributes equipment and solutions for ophthalmology and microsurgery, serving hospitals, clinics and medical professionals worldwide.
Its ophthalmic portfolio includes diagnostic systems for examining the eye, equipment for cataract and refractive surgery, surgical lasers, intraocular lenses and other related products. The company also supplies surgical microscopes, visualization systems and digital technologies used in neurosurgery, spine surgery, ear, nose and throat procedures, and other microsurgical specialties.
Carl Zeiss Meditec was established in 2002 through the combination of the ophthalmic activities of Carl Zeiss and Asclepion-Meditec.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
